Oskare Capital
Finance · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
154 Rue De Lourmel, Paris, Ile-de-France...Website
www.oskarecapital.comRevenue
<$5 MillionIndustry
About Oskare Capital
Is Oskare Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Oskare Capital
Check out if Oskare Capital is spiking on competitors!
Check if Oskare Capital has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Oskare Capital has new funding data
Product Launch: Get notified when Oskare Capital launches new products
Earning: See what the market has to say on Oskare Capital recently announced quarterly report
Website visits: Recent activity has been detected on your website
Oskare Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Oskare Capital had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Oskare Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Oskare Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Oskare Capital.
Oskare Capital Tech Stack
A closer look at the technologies used by Oskare Capital
Oskare Capital News & Media
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oskare Capital
Óskare Capital is headquartered in Paris and London, specializing in venture-stage investments in sectors such as Deeptech and Life Sciences. The company's current portfolio includes innovative firms like Octarine, which focuses on synthetic biology, and Leva, a digital clinic addressing chronic pain. Óskare also invests in Herbolea, which transfor... Read More